Haftungsausschluss: Diese Website bündelt öffentlich verfügbare Daten aus offiziellen Quellen wie FDA, ClinicalTrials.gov, PubMed und SEC EDGAR nur zur allgemeinen Information. Sie stellt keine medizinische Beratung, Diagnose, Behandlungsempfehlung oder Anlageberatung dar.

FDA-PMA

Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation

PMA-Nummer: P220013 · 2026-09-22

AntragstellerABBOTT MEDICAL
Entscheidungsdatum2026-09-22
PMA-NummerP220013
ProduktcodeOAE
GeräteklasseKlasse 3
Medizinische FachrichtungU
BeratungsausschussCV

Produktübersicht

Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation is the device name listed in this FDA 510(k) record. The listed applicant is ABBOTT MEDICAL. It received FDA 510(k) clearance on 2026-09-22. The device is classified under product code OAE. It was reviewed by the CV advisory panel.

Häufig gestellte Fragen

What is the Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation?

Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation is a medical device that received FDA 510(k) clearance on 2026-09-22. The listed applicant is ABBOTT MEDICAL.

When did Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation receive FDA 510(k) clearance?

The clearance date for Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation can be found in the official FDA records.

Who is the listed applicant for Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation?

The FDA 510(k) record lists ABBOTT MEDICAL as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation?

The FDA product code for Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation is OAE.

Zugehörige klinische Studien

Zugehörige Einträge werden automatisch anhand von Namen, Produktcodes oder anderen Metadaten abgeglichen. Eine Übereinstimmung begründet kein verifiziertes klinisches, wissenschaftliches, unternehmerisches oder regulatorisches Verhältnis; prüfen Sie die verlinkten offiziellen Quellen.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Offizielle Quelle

In der FDA-Datenbank anzeigen →

Daten aus der FDA Open API. Für die aktuellsten und verbindlichen Informationen konsultieren Sie bitte stets den offiziellen Datensatz.

↑